Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.

Research for Patient Benefit Programme Yorkshire & North East Competition 51 Stage 2 and Competition 52 Stage 1 Minutes

Contents

Published: 15 March 2024

Version: 1.0 March 2024

Print this document

Minutes for the Research for Patient Benefit (RfPB) programme Yorkshire and North East Regional Advisory Committee meeting to discuss Stage 2 applications to Competition 51 and Stage 1 applications to Competition 52.

Date and Location

Wednesday 17 January 2024 Virtual Online Meeting 

In attendance

  • Dr Judith Cohen (Chair)
  • Victoria Bartle
  • Mrs Samina Begum
  • Mrs Anne Benson
  • Professor Ann-Louise Caress
  • Professor Peter Day
  • Dr Emma Giles
  • Dr Julia Hackett
  • Professor Andy Husband
  • Dr Laura Jefferson
  • Dr Rachael Kelley
  • Mrs Ellen Lee
  • Professor Rory O’Connor
  • Dr Samuel Smith
  • Mrs Jan Speechley
  • Professor Claire Surr
  • Dr Eugene Tang
  • Ms Alexandra Wright-Hughes

Secretariat

  • Dr Diana Kyriazis (NIHRCC)
  • Dr Jennie Hejdenberg (NIHRCC)
  • Ms Sarah Deria (NIHRCC)
  • Ms Lauren McKelvie (NIHRCC)

Programme Director

  • Professor Kevin Munro 

Observers

  • Professor Caitlin Notley - EE Chair
  • Ms Jennie Lister- RSS York
  • Dr Antonia Marsden- RSS Lancaster
  • Dr Caroline Webb- NIHR School for Social Care Research

Competition 51 Stage 2 applications considered

NIHR206746: Enabling Service Users with Severe Mental Illness to Learn about and Engage (SMILE) with Good Oral Health: Co-production, Feasibility and Acceptability of a Systems intervention
Conflicts: Dr Judith Cohen, Professor Peter Day, Dr Laura Jefferson, Mrs Ellen Lee, Professor Emma Giles

Final outcome: Conditional support

NIHR206579: Evaluating a Standardised Post-diagnostic Strengths and Needs Assessment for Autistic Adults: an Acceptability and Feasibility Study
Conflicts: Professor Peter Day, Mrs Ellen Lee

Final outcome: Conditional support

NIHR206739: Telehealth to reduce compound pressures on the NHS and Social Care
Conflicts: None

Final outcome: Conditional support

NIHR206602: Virtual Reality for Visions (VRV):  a proof of concept study examining the development of a new treatment for distressing visual hallucinations in people with psychosis.
Conflicts: Victoria Bartle

Final outcome: Re-Invite to Stage 2

NIHR207256: Randomised controlled efficacy trial (RCT) of isometric exercise (IE) in adults with stage 1 and 2 hypertension. (ISOFITTER)
Conflicts: None

Final outcome: Conditional support

Stage 1 applications considered

NIHR207148:  Lithium point-of-care testing to improve adherence to monitoring guidelines and quality of maintenance therapy for bipolar disorder: a randomised feasibility trial
Conflicts: Mrs Samina Begum

Outcome: Invite to Stage 2

NIHR207223: Optimising cancer screening and surveillance provision and uptake for people with cystic fibrosis: a qualitative study to identify and understand clinician and patient challenges and needs and ways to address these.
Conflicts: Dr Rachael Kelley, Professor Rory O'Connor, Professor Claire Surr

Outcome: Invite to Stage 2

NIHR207177: Addressing ethniC inequaliTies In healthcare use and quality amONg people with painful Diabetic Neuropathy (ACTION-DN)
Conflicts: Dr Judith Cohen, Mrs Samina Begum, Mrs Ellen Lee, Professor Rory O'Connor

Outcome: Invite to Stage 2

NIHR207127: Determining how Health Visitors can be agents of change alongside parents in reducing the prevalence/mitigating the risk of alcohol related developmental disorders in England: exploratory mixed methods study
Conflicts: Dr Judith Cohen

Outcome: Invite to Stage 2

NIHR207155: A pilot randomised controlled trial of the effectiveness and cost-effectiveness of a brief alcohol intervention with falls services: The SAFE-PACE study.
Conflicts: Dr Judith Cohen, Professor Emma Giles

Outcome: Reject

NIHR207117: The Acceptability and Feasibility of a Behavioral Activation Informed Treatment for Depression in Adolescents with Autism Spectrum Disorder
Conflicts: None

Outcome: Reject

NIHR207196: Randomised trial on normal saline versus lactate Ringer’s solution for acute pancreatitis: UK-arm of the WATERLAND trial
Conflicts: None

Outcome: Reject

NIHR207198: Upper Limb Telerehabilitation Using Brain-Controlled Functional Electrical Stimulation (a co-designed system improvement followed by a pilot randomised controlled trial)
Conflicts: Mrs Ellen Lee, Professor Peter Day

Outcome: Reject

NIHR207204: Defining the cost-effective symptom level to guide tonsillectomy in adults with recurrent tonsillitis
Conflicts: Professor Andy Husband, Professor Rory O'Connor

Outcome: Reject

NIHR207131: Safe Withdrawal of Immunosuppression in Renal Lupus. The SWIRL feasibility trial
Conflicts: Ms Alexandra Wright-Hughes

Outcome: Reject

NIHR207207: CpepWell - Is overall well-being in established type 1 diabetes associated with level of residual insulin production (C-peptide) and is measuring this valuable to people with diabetes and their health care providers?
Conflicts: Dr Eugene Tang

Outcome: Reject

NIHR207179: CRoss-Education And Mirror Therapy (CREAM-T) for the treatment of unilateral ankle fracture
Conflicts: Dr Judith Cohen, Professor Emma Giles

Outcome: Reject

Outcomes Table

The tables below display the mean scores for each application that was assessed in the regional assessment committee meeting. They exclude applications that were rejected during the scrutiny and triage processes. 

The number of applications receiving each mean score is listed. The fundable range is 4-6 although a score of 4-6 does not guarantee funding or an invitation to Stage 2. 

In exceptional circumstances and with approval from the Programme Director, applications may be invited/funded which fall below the fundable range.  

Stage 2

ScoreNumber of Applications FundedNumber of Applications Rejected
5.0-6.0 2 0
4.0-4.9 2 0
3.0-3.9 1 1
2.0-2.9 0 0
1.0-1.9 0 0

Stage 1

ScoreNumber of Applications FundedNumber of Applications Rejected
5.0-6.0 0 0
4.0-4.9 3 0
3.0-3.9 1 2
2.0-2.9 0 5
1.0-1.9 0 1